EMEA-001363-PIP01-12-M01 - paediatric investigation plan

Thrombomodulin alfa

Key facts

• Active Substance:
  Thrombomodulin alfa
• Therapeutic area:
  Infectious diseases
• Decision number:
  P/0346/2017
• PIP number:
  EMEA-001363-PIP01-12-M01
• Pharmaceutical form(s):
  Solution for infusion
• Condition(s) / indication(s):
  Treatment of sepsis
• Route(s) of administration:
  Intravenous use
• Contact for public enquiries:

  Asahi Kasei Pharma America Corporation

  Tel. [phone]; E-mail: [e-mail]

• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  01/12/2017

Decision

P/0346/2017: EMA decision of 1 December 2017 on the acceptance of a modification of an agreed paediatric investigation plan for thrombomodulin alfa (EMEA-001363-PIP01-12-M01)

Reference Number: EMA/709640/2017 Corr